Insmed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1998
Net Income	-749.57	-481.53	-434.65	-294.09	-254.34	Upgrade
Depreciation & Amortization	19.79	22.31	26.77	20.08	19.94	Upgrade
Share-Based Compensation	74.78	57.69	46.02	36.16	26.97	Upgrade
Other Operating Activities	118.76	1.1	-1.44	18.5	-43.23	Upgrade
Operating Cash Flow	-536.25	-400.44	-363.3	-219.35	-250.65	Upgrade
Capital Expenditures	-13.29	-9.88	-7.29	-6.24	-42.27	Upgrade
Acquisitions	3.42	0	-6.7	0	0	Upgrade
Change in Investments	-213.73	-24.71	-50.29	0	0	Upgrade
Other Investing Activities	-	-	-	-0.58	-	Upgrade
Investing Cash Flow	-223.6	-34.58	-64.29	-6.82	-42.27	Upgrade
Share Issuance / Repurchase	170.87	311.66	291.92	271.94	280.78	Upgrade
Debt Issued / Paid	-2.44	481.62	320.62	0	0	Upgrade
Other Financing Activities	-	-	-	-0.94	4.5	Upgrade
Financing Cash Flow	168.44	793.27	612.55	271	285.28	Upgrade
Exchange Rate Effect	-0.25	-1	-0.93	0.49	-0	Upgrade
Net Cash Flow	-591.66	357.25	184.03	45.33	-7.64	Upgrade
Free Cash Flow	-549.54	-410.32	-370.59	-225.59	-292.92	Upgrade
Free Cash Flow Margin	-180.05%	-167.23%	-196.64%	-137.21%	-214.64%	Upgrade
Free Cash Flow Per Share	-3.91	-3.33	-3.31	-2.31	-3.46	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).